Strattera 18mg hard capsules 28’s


Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme

SKU: PHARM_4D37K Categories: , Tag:


Each hard capsule contains atomoxetine hydrochloride equivalent to 18 mg of atomoxetine.

Treatment must be initiated by a specialist in the treatment of ADHD, such as a pediatrician, child/adolescent psychiatrist, or psychiatrist. Diagnosis should be made according to current DSM criteria or the guidelines in ICD.

In adults, the presence of symptoms of ADHD that were pre-existing in childhood should be confirmed. Third-party corroboration is desirable and Strattera should not be initiated when the verification of childhood ADHD symptoms is uncertain. Diagnosis cannot be made solely on the presence of one or more symptoms of ADHD.

Strattera can be administered as a single daily dose in the morning. Patients who do not achieve a satisfactory clinical response (tolerability e.g. nausea or somnolence or efficacy) when taking Strattera as a single daily dose might benefit from taking it as twice daily evenly divided doses in the morning and late afternoon or early evening.


There are no reviews yet.

Be the first to review “Strattera 18mg hard capsules 28’s”

Your email address will not be published. Required fields are marked *